In another study on patients with non-alcoholic fatty liver disease (NAFLD), those with NAFLD and fibrosis presented higher plasma levels of PTX3 than both NAFLD patients without fibrosis and the controls (p = 0.032 and p = 0.028, respectively) [27]. Here, PTX3 is linked to metabolic dysfunction-associated steatotic liver disease.